Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 27


Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome.

El-Assaad F, Krilis SA, Giannakopoulos B.

Thromb J. 2016 Oct 4;14(Suppl 1):20.


Gram Negative Bacterial Inflammation Ameliorated by the Plasma Protein Beta 2-Glycoprotein I.

Zhou S, Chen G, Qi M, El-Assaad F, Wang Y, Dong S, Chen L, Yu D, Weaver JC, Beretov J, Krilis SA, Giannakopoulos B.

Sci Rep. 2016 Sep 27;6:33656. doi: 10.1038/srep33656.


The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury.

Zhang P, Weaver JC, Chen G, Beretov J, Atsumi T, Qi M, Bhindi R, Qi JC, Madigan MC, Giannakopoulos B, Krilis SA.

PLoS One. 2016 Mar 31;11(3):e0152681. doi: 10.1371/journal.pone.0152681.


CD117+ Dendritic and Mast Cells Are Dependent on RasGRP4 to Function as Accessory Cells for Optimal Natural Killer Cell-Mediated Responses to Lipopolysaccharide.

Zhou S, Tanaka K, O'Keeffe M, Qi M, El-Assaad F, Weaver JC, Chen G, Weatherall C, Wang Y, Giannakopoulos B, Chen L, Yu D, Hamilton MJ, Wensing LA, Stevens RL, Krilis SA.

PLoS One. 2016 Mar 16;11(3):e0151638. doi: 10.1371/journal.pone.0151638.


Improved Assay for Quantifying a Redox Form of Angiotensinogen as a Biomarker for Pre-Eclampsia: A Case-Control Study.

Rahgozar S, Amirian T, Qi M, Shahshahan Z, Entezar-E-Ghaem M, Ghasemi Tehrani H, Miroliaei M, Krilis SA, Giannakopoulos B.

PLoS One. 2015 Aug 27;10(8):e0135905. doi: 10.1371/journal.pone.0135905.


Do Beta 2-Glycoprotein I Disulfide Bonds Protect the Human Retina in the Setting of Age-Related Macular Degeneration?

Qi M, Abdelatti M, Krilis M, Madigan MC, Weaver J, Guymer RH, McCluskey P, Wang Y, Zhou S, Krilis SA, Giannakopoulos B.

Antioxid Redox Signal. 2016 Jan 1;24(1):32-8. doi: 10.1089/ars.2014.6052.


Laboratory methods to detect antiphospholipid antibodies.

Krilis SA, Giannakopoulos B.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):321-8. doi: 10.1182/asheducation-2014.1.321. Review.


Deletion of the antiphospholipid syndrome autoantigen β2 -glycoprotein I potentiates the lupus autoimmune phenotype in a Toll-like receptor 7-mediated murine model.

Giannakopoulos B, Mirarabshahi P, Qi M, Weatherall C, Qi JC, Tanaka K, Millar E, Vonthethoff L, Gatto D, Spielman D, Krilis SA.

Arthritis Rheumatol. 2014 Aug;66(8):2270-80. doi: 10.1002/art.38646.


In APS, two A1's are better than one!

Giannakopoulos B, Krilis S.

Blood. 2014 Feb 13;123(7):955-6. doi: 10.1182/blood-2013-12-542506. No abstract available.


The pathogenesis of the antiphospholipid syndrome.

Giannakopoulos B, Krilis SA.

N Engl J Med. 2013 Mar 14;368(11):1033-44. doi: 10.1056/NEJMra1112830. Review. No abstract available.


Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis.

Giannakopoulos B, Gao L, Qi M, Wong JW, Yu DM, Vlachoyiannopoulos PG, Moutsopoulos HM, Atsumi T, Koike T, Hogg P, Qi JC, Krilis SA.

J Autoimmun. 2012 Sep;39(3):121-9. doi: 10.1016/j.jaut.2012.05.005.


APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking.

Erkan D, Lockshin MD; APS ACTION members..

Lupus. 2012 Jun;21(7):695-8. doi: 10.1177/0961203312437810.


Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.

Passam FH, Giannakopoulos B, Mirarabshahi P, Krilis SA.

J Thromb Haemost. 2011 Jul;9 Suppl 1:275-82. doi: 10.1111/j.1538-7836.2011.04301.x. Review.


Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.

Ioannou Y, Zhang JY, Qi M, Gao L, Qi JC, Yu DM, Lau H, Sturgess AD, Vlachoyiannopoulos PG, Moutsopoulos HM, Rahman A, Pericleous C, Atsumi T, Koike T, Heritier S, Giannakopoulos B, Krilis SA.

Arthritis Rheum. 2011 Sep;63(9):2774-82. doi: 10.1002/art.30383.


New insights into the biology and pathobiology of beta2-glycoprotein I.

Giannakopoulos B, Mirarabshahi P, Krilis SA.

Curr Rheumatol Rep. 2011 Feb;13(1):90-5. doi: 10.1007/s11926-010-0151-9. Review.


Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1.

Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JW, Tanaka K, Ioannou Y, Zhang JY, Gemmell R, Qi JC, Giannakopoulos B, Hughes WE, Hogg PJ, Krilis SA.

J Thromb Haemost. 2010 Aug;8(8):1754-62. doi: 10.1111/j.1538-7836.2010.03944.x.


Beta 2 glycoprotein I is a substrate of thiol oxidoreductases.

Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JW, Tanaka K, Ioannou Y, Zhang JY, Gemmell R, Qi JC, Giannakopoulos B, Hughes WE, Hogg PJ, Krilis SA.

Blood. 2010 Sep 16;116(11):1995-7. doi: 10.1182/blood-2010-02-271494. No abstract available.


Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury.

Ioannou Y, Zhang JY, Passam FH, Rahgozar S, Qi JC, Giannakopoulos B, Qi M, Yu P, Yu DM, Hogg PJ, Krilis SA.

Blood. 2010 Sep 16;116(11):1961-70. doi: 10.1182/blood-2009-04-215335.


How I treat the antiphospholipid syndrome.

Giannakopoulos B, Krilis SA.

Blood. 2009 Sep 3;114(10):2020-30. doi: 10.1182/blood-2009-05-220756. Review.


Ro 60 functions as a receptor for beta(2)-glycoprotein I on apoptotic cells.

Reed JH, Giannakopoulos B, Jackson MW, Krilis SA, Gordon TP.

Arthritis Rheum. 2009 Mar;60(3):860-9. doi: 10.1002/art.24361.

Items per page

Supplemental Content

Loading ...
Support Center